STOK (STOCKS)
Stoke Therapeutics, Inc. Common Stock
$35.050000
+0.720000 (+2.10%)
Prev close: $34.330000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Ian Frederick Smith
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,072.05M
- Employees
- 128
- P/E (TTM)
- -236.03
- P/B (TTM)
- 5.74
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $184.42M |
| Benefits Costs and Expenses | $191.31M |
| Costs And Expenses | $191.31M |
| Nonoperating Income/Loss | $13.71M |
| Operating Expenses | $205.01M |
| Selling, General, and Administrative Expenses | $67.09M |
| Research and Development | $137.92M |
| Operating Income/Loss | -$20.59M |
| Income/Loss From Continuing Operations After Tax | -$6.89M |
| Income/Loss From Continuing Operations Before Tax | -$6.89M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Expense, Operating | $9.00K |
| Net Income/Loss | -$6.89M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$6.89M |
| Net Income/Loss Available To Common Stockholders, Basic | -$6.89M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.12 |
| Diluted Earnings Per Share | -$0.12 |
| Basic Average Shares | 59,219,184 |
| Diluted Average Shares | 59,219,184 |
| Assets | $418.43M |
| Current Assets | $305.70M |
| Prepaid Expenses | $8.74M |
| Other Current Assets | $296.96M |
| Noncurrent Assets | $112.73M |
| Fixed Assets | $3.15M |
| Other Non-current Assets | $109.59M |
| Liabilities | $65.98M |
| Current Liabilities | $57.88M |
| Accounts Payable | $4.94M |
| Other Current Liabilities | $52.94M |
| Noncurrent Liabilities | $8.10M |
| Equity | $352.46M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $352.46M |
| Liabilities And Equity | $418.43M |
| Net Cash Flow From Operating Activities | $45.59M |
| Net Cash Flow From Operating Activities, Continuing | $45.59M |
| Net Cash Flow From Investing Activities | -$186.81M |
| Net Cash Flow From Investing Activities, Continuing | -$186.81M |
| Net Cash Flow From Financing Activities | $97.39M |
| Net Cash Flow From Financing Activities, Continuing | $97.39M |
| Net Cash Flow | -$43.84M |
| Net Cash Flow, Continuing | -$43.84M |
| Comprehensive Income/Loss | -$6.19M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$6.19M |
| Other Comprehensive Income/Loss | $694.00K |